Valvular Heart Disease in Relation to Race and Ethnicity JACC Focus Seminar 4/9

Valvular heart disease (VHD) is a major global public health problem. Many regions of the world continue to grapple with the adverse consequences of untreated rheumatic heart disease, a condition that is largely preventable with timely access to diagnosis and treatment. In turn, middle- and high-income countries have experienced a rise in the prevalence of calcific aortic and mitral disease, owing in part to population aging. This public health problem is further compounded by high rates of infective endocarditis, which is associated with substantial morbidity and mortality. Yet, considerations of race and ethnicity have not taken center stage in VHD research. This is despite evidence of major health care disparities in socioeconomic and medical risk factors, access to diagnosis, and provision of appropriate treatment. In this paper, the authors review differences in the etiology, diagnosis, and treatment of VHD within the context of race, ethnicity, and health care disparities. (C) 2021 by the American College of Cardiology Foundation.

Automated summary

Valvular heart disease poses a significant global public health challenge, with untreated rheumatic heart disease causing grave consequences. The role of race, ethnicity, and healthcare disparities in VHD research has been overlooked, despite evidence of major health care inequalities.